Freedom Investment Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,299
Closed -$280K 842
2023
Q4
$280K Buy
2,299
+435
+23% +$48.5K 0.02% 616
2023
Q3
$209K Sell
1,864
-283
-13% -$35.9K 0.03% 614
2023
Q2
$313K Buy
+2,147
New +$292K 0.04% 529
2018
Q1
Sell
-3,204
Closed -$375K 1231
2017
Q4
$375K Buy
+3,204
New +$362K 0.02% 774
2017
Q2
Sell
-6,389
Closed -$757K 1138
2017
Q1
$757K Sell
6,389
-1,987
-24% -$225K 0.04% 389
2016
Q4
$839K Sell
8,376
-2,686
-24% -$288K 0.05% 301
2016
Q3
$1.4M Sell
11,062
-490
-4% -$60.5K 0.09% 155
2016
Q2
$1.35M Buy
11,552
+1,216
+12% +$138K 0.09% 144
2016
Q1
$1.07M Buy
10,336
+2,902
+39% +$281K 0.08% 195
2015
Q4
$740K Sell
7,434
-37,460
-83% -$3.67M 0.06% 278
2015
Q3
$1.59M Buy
+44,894
New +$4.5M 0.16% 90

Other funds holding ZBH

Freedom Investment Management's ZBH Position: Q1 2024 in Review

Freedom Investment Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 2,299 shares — an estimated $280K sold.

Freedom Investment Management first reported a position in ZBH in Q3 2015 and held it in 11 quarters. The position peaked at $1.59M in Q3 2015. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Freedom Investment Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Freedom Investment Management sold 2,299 Zimmer Biomet shares in Q1 2024, an estimated $280K.
  • Freedom Investment Management first reported a position in Zimmer Biomet in Q3 2015 and held it in 11 quarters.
  • Freedom Investment Management's Zimmer Biomet position peaked at $1.59M in Q3 2015.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Freedom Investment Management's 13F filing for Q1 2024, filed 14 May 2024.